Long-Term Assets: The sum of all assets classified as non-current.
Axsome Therapeutics, Inc. (AXSM) had Long-Term Assets of $102.04M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$121.46M |
|
$-59.41M |
|
$9.79M |
|
$111.67M |
|
$178.44M |
|
$-56.98M |
|
$-2.43M |
|
$-59.41M |
|
$-59.41M |
|
$-59.41M |
|
$-59.41M |
|
$-59.41M |
|
$-59.41M |
|
$-56.98M |
|
$-54.18M |
|
48.87M |
|
48.87M |
|
$-1.22 |
|
$-1.22 |
|
| Balance Sheet Financials | |
$494.63M |
|
$0.77M |
|
|
Long-Term Assets |
$102.04M |
$596.67M |
|
$243.91M |
|
$185.06M |
|
$299.55M |
|
$543.47M |
|
$53.21M |
|
$-4.16M |
|
$53.20M |
|
49.22M |
|
| Cash Flow Statement Financials | |
$-43.38M |
|
$-0.34M |
|
$29.27M |
|
$315.35M |
|
$300.91M |
|
$-14.44M |
|
$23.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.03 |
|
-- |
|
-- |
|
0.78 |
|
3.48 |
|
91.94% |
|
-46.91% |
|
-46.91% |
|
-- |
|
-48.91% |
|
-48.91% |
|
$-43.71M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.60 |
|
0.75 |
|
119.59 |
|
-111.67% |
|
1428.55% |
|
-9.96% |
|
-24.94% |
|
$1.08 |
|
$-0.89 |
|
$-0.89 |
|